[1] Mayhew TM, Manwani R, Ohadike C, et al.The placenta in pre-eclampsia and intrauterine growth restriction: studies on exchange surface areas, diffusion distances and villous membrane diffusive conductances[J]. Placenta,2007,28(2-3):233-238. [2] Roberge S, Odibo AO, Bujold E.Aspirin for the prevention of preeclampsia and intrauterine growth restriction[J]. Clin Lab Med,2016,36(2):319-329. [3] Gómez O, Martínez JM, Figueras F, et al.Uterine artery Doppler at 11-14 weeks of gestation to screen for hypertensive disorders and associated complications in an unselected population[J]. Ultrasound Obstet Gynecol,2005, 26(5):490-494. [4] Pilalis A, Souka AP, Antsaklis P, et al.Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation[J]. Ultrasound Obstet Gynecol,2007,29(2):135-140. [5] Hafner E, Schuchter K, Metzenbauer M, et al.Uterine artery Doppler perfusion in the first and second pregnancies[J]. Ultrasound Obstet Gynecol,2000,16(7):625-629. [6] Dugoff L, Lynch AM, Cioffi-Ragan D, et al.First trimester uterine artery Doppler abnormalities predict subsequent intrauterine growth restriction[J]. Am J Obstet Gynecol,2005,193(3 Pt 2):1208-1212. [7] Talbert DG.Uterine flow velocity waveform shape as an indicator of maternal and placental development failure mechanisms: a model-based synthesizing approach[J]. Ultrasound Obstet Gynecol,1995,6(4):261-271. [8] Ohkuchi A, Minakami H, Sato I, et al.Predicting the risk of pre-eclampsia and a small-for-gestational-age infant by quantitative assessment of the diastolic notch in uterine artery flow velocity waveforms in unselected women[J]. Ultrasound Obstet Gynecol,2000,16(2):171-178. [9] Bower S, Kingdom J, Campbell S.Objective and subjective assessment of abnormal uterine artery Doppler flow velocity waveforms[J]. Ultrasound Obstet Gynecol,1998, 12(4):260-264. [10] Aardema MW, De Wolf BT, Saro MC, et al.Quantification of the diastolic notch in Doppler ultrasound screening of uterine arteries[J]. Ultrasound Obstet Gynecol,2000, 16(7):630-634. [11] Lawrence JB, Oxvig C, Overgaard MT, et al.The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A[J]. Proc Natl Acad Sci U S A,1999,96(6):3149-3153. [12] Clemmons DR.Role of insulin-like growth factor binding proteins in controlling IGF actions[J]. Mol Cell Endocrinol,1998,140(1-2):19-24. [13] Yaron Y, Heifetz S, Ochshorn Y, et al.Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome[J]. Prenat Diagn,2002,22(9):778-782. [14] Zhong Y, Tuuli M, Odibo AO.First-trimester assessment of placenta function and the prediction of preeclampsia and intrauterine growth restriction[J]. Prenat Diagn,2010, 30(4):293-308. |